Compare Pfizer Inc (PFE) vs Xcel Energy Inc (XEL) Price & Performance

Pfizer (PFE) trades at $28.00, up 1.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $62.58 billion in 2025 with a net income margin of 6.8%, and has beaten EPS estimates for the last three quarters. Recent news highlights Pfizer's focus on its obesity and oncology pipeline as key growth drivers in 2026.

The stock presents a value opportunity with a consensus price target of $29.17, but faces risks from patent expirations and projected earnings decline. Investor sentiment is mixed, with analysts largely neutral, emphasizing the stock's defensive cash flow and dividend yield amid ongoing business transformation.

Xcel Energy (XEL) trades at $72.42, down 0.43% with bearish technical signals despite recent earnings beats. The stock shows solid fundamentals with $14.67B revenue, 15.28% net margin, and consistent dividend payments. Analyst consensus remains bullish with a $90.83 price target, though technical indicators show RSI overbought conditions and bearish moving average signals. Recent news highlights growth from data center power demand and infrastructure investments.

XEL offers steady utility exposure with 62.96% analyst buy ratings and 3.3% dividend yield. Key opportunities include $60B capex plan and data center demand growth, while risks involve wildfire liabilities, rising debt levels, and regulatory pressures. The stock trades at reasonable valuations (P/E 19.84) with potential 25% upside to consensus target.